Skip to content
10-Q

Quarterly Report

Bioventus Inc. BVS

0001665988-25-000017

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 28, 2025 68.54M sh
Shares Diluted Q2 2025 · Jun 28, 2025 68.77M sh
Shares Diluted Q2 2025 · Jun 29, 2024 64.06M sh
Shares Diluted Q2 2025 · Jun 29, 2024 63.72M sh
Capex Q2 2025 · Jun 28, 2025 $1.51M
Capex Q2 2025 · Jun 29, 2024 $368K
Operating Cash Flow Q2 2025 · Jun 28, 2025 $6.61M
Operating Cash Flow Q2 2025 · Jun 29, 2024 $9.16M
Long Term Debt Q2 2025 · Jun 28, 2025 $297.88M
Long Term Debt Q2 2025 · Dec 31, 2024 $308.29M
Short Term Debt Q2 2025 · Jun 28, 2025 $43.36M
Short Term Debt Q2 2025 · Dec 31, 2024 $27.34M
Cash And Equivalents Q2 2025 · Jun 28, 2025 $32.91M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $41.58M
Stockholders Equity Q2 2025 · Jun 28, 2025 $161.24M
Stockholders Equity Q2 2025 · Dec 31, 2024 $147.94M
Current Liabilities Q2 2025 · Jun 28, 2025 $185.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $210.4M
Total Liabilities Q2 2025 · Jun 28, 2025 $505.49M
Total Liabilities Q2 2025 · Dec 31, 2024 $542.35M
Current Assets Q2 2025 · Jun 28, 2025 $275.2M
Current Assets Q2 2025 · Dec 31, 2024 $275.61M
Total Assets Q2 2025 · Jun 28, 2025 $706.79M
Total Assets Q2 2025 · Dec 31, 2024 $727.96M
Eps Diluted Q2 2025 · Jun 28, 2025 $0.11
Eps Diluted Q2 2025 · Jun 28, 2025 $0.07
Eps Diluted restated Q2 2025 · Jun 29, 2024 −$0.40
Eps Diluted restated Q2 2025 · Jun 29, 2024 −$0.48
Eps Basic Q2 2025 · Jun 28, 2025 $0.11
Eps Basic Q2 2025 · Jun 28, 2025 $0.07
Eps Basic restated Q2 2025 · Jun 29, 2024 −$0.40
Eps Basic restated Q2 2025 · Jun 29, 2024 −$0.48
Sga Expense Q2 2025 · Jun 28, 2025 $79.11M
Sga Expense Q2 2025 · Jun 28, 2025 $152.61M
Sga Expense restated Q2 2025 · Jun 29, 2024 $96.67M
Sga Expense restated Q2 2025 · Jun 29, 2024 $175.44M
Rd Expense Q2 2025 · Jun 28, 2025 $3.17M
Rd Expense Q2 2025 · Jun 28, 2025 $6.18M
Rd Expense restated Q2 2025 · Jun 29, 2024 $4.21M
Rd Expense restated Q2 2025 · Jun 29, 2024 $6.84M
Net Income Q2 2025 · Jun 28, 2025 $7.46M
Net Income Q2 2025 · Jun 28, 2025 $4.82M
Net Income restated Q2 2025 · Jun 29, 2024 −$25.68M
Net Income restated Q2 2025 · Jun 29, 2024 −$30.57M
Operating Income Q2 2025 · Jun 28, 2025 $18.37M
Operating Income Q2 2025 · Jun 28, 2025 $23.24M
Operating Income restated Q2 2025 · Jun 29, 2024 −$31.47M
Operating Income restated Q2 2025 · Jun 29, 2024 −$26.55M
Gross Profit Q2 2025 · Jun 28, 2025 $102.09M
Gross Profit Q2 2025 · Jun 28, 2025 $185.15M
Gross Profit Q2 2025 · Jun 29, 2024 $103.64M
Gross Profit Q2 2025 · Jun 29, 2024 $192.02M
Cost Of Revenue Q2 2025 · Jun 28, 2025 $45.57M
Cost Of Revenue Q2 2025 · Jun 28, 2025 $86.39M
Cost Of Revenue Q2 2025 · Jun 29, 2024 $47.58M
Cost Of Revenue Q2 2025 · Jun 29, 2024 $88.66M
Revenue Q2 2025 · Jun 28, 2025 $147.66M
Revenue Q2 2025 · Jun 28, 2025 $271.54M
Revenue Q2 2025 · Jun 29, 2024 $151.22M
Revenue Q2 2025 · Jun 29, 2024 $280.67M